Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. Ginipral
2. Gynipral
3. Hexoprenaline
4. Ipradol
5. St 1512
6. St-1512
7. St1512
8. Sulfate, Hexoprenaline
1. Gynipral
2. Bronalin
3. Etoscol
4. 32266-10-7
5. Leanol
6. 30117-45-4
7. Delaprem
8. Hexoprenaline Sulphate
9. Nsc-292266
10. St1512/so4
11. 4,4'-[hexane-1,6-diylbis[imino(1-hydroxyethylene)]]dipyrocatechol Sulphate
12. Dsstox_cid_26688
13. Dsstox_rid_81822
14. Dsstox_gsid_46688
15. Hexoprenaline Sulfate (usan)
16. Hexoprenalinesulphate
17. Hexoprenaline Sulfate [usan]
18. 4,4'-(hexane-1,6-diylbis(imino(1-hydroxyethylene)))dipyrocatechol Sulphate
19. 4-[2-[6-[[2-(3,4-dihydroxyphenyl)-2-hydroxyethyl]amino]hexylamino]-1-hydroxyethyl]benzene-1,2-diol;sulfuric Acid
20. Cas-32266-10-7
21. U851s9102c
22. Ncgc00167522-01
23. Delaprem (tn)
24. Einecs 250-057-2
25. 1,2-benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-, Sulfate (1:1) (salt)
26. Schembl598186
27. Chembl2104813
28. Dtxsid6046688
29. Chebi:31670
30. Hexoprenaline Sulfate [mi]
31. Hexoprenaline Sulfate [jan]
32. St-1512/so4
33. Tox21_112519
34. Nsc292266
35. Hexoprenaline Sulfate [mart.]
36. Hexoprenaline Sulfate [who-dd]
37. Tox21_112519_1
38. Ncgc00167522-02
39. D02396
40. Q27290818
41. 1, 4,4'-[1,6-hexanediylbis[imino(1-hydroxy-2,1-ethanediyl)]]bis-, Sulfate (1:1) (salt)
42. (+/-)-.alpha.,.alpha.'-(hexamethylenebis(iminomethylene))bis(3,4-dihydroxybenzyl Alcohol) Sulfate (1:1) (salt)
43. (+/-)-.alpha.,.alpha.'-(hexamethylenebis(iminomethylene))bis(3,4-dihydroxybenzyl Alcohol) Sulphate (1:1) (salt)
44. 1,2-benzenediol, 4,4'-(1,6-hexanediylbis(imino(1-hydroxy-2,1-ethanediyl)))bis-, Sulphate (1:1) (salt)
| Molecular Weight | 518.6 g/mol |
|---|---|
| Molecular Formula | C22H34N2O10S |
| Hydrogen Bond Donor Count | 10 |
| Hydrogen Bond Acceptor Count | 12 |
| Rotatable Bond Count | 13 |
| Exact Mass | 518.19341646 g/mol |
| Monoisotopic Mass | 518.19341646 g/mol |
| Topological Polar Surface Area | 228 Ų |
| Heavy Atom Count | 35 |
| Formal Charge | 0 |
| Complexity | 499 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 2 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Bronchodilator Agents
Agents that cause an increase in the expansion of a bronchus or bronchial tubes. (See all compounds classified as Bronchodilator Agents.)
Adrenergic beta-2 Receptor Agonists
Compounds bind to and activate ADRENERGIC BETA-2 RECEPTORS. (See all compounds classified as Adrenergic beta-2 Receptor Agonists.)
Tocolytic Agents
Drugs that prevent preterm labor and immature birth by suppressing uterine contractions (TOCOLYSIS). Agents used to delay premature uterine activity include magnesium sulfate, beta-mimetics, oxytocin antagonists, calcium channel inhibitors, and adrenergic beta-receptor agonists. The use of intravenous alcohol as a tocolytic is now obsolete. (See all compounds classified as Tocolytic Agents.)
API SUPPLIERS
FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]
Market Place
ABOUT THIS PAGE
A Hexoprenaline manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Hexoprenaline, including repackagers and relabelers. The FDA regulates Hexoprenaline manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Hexoprenaline API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Hexoprenaline manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.
A Hexoprenaline supplier is an individual or a company that provides Hexoprenaline active pharmaceutical ingredient (API) or Hexoprenaline finished formulations upon request. The Hexoprenaline suppliers may include Hexoprenaline API manufacturers, exporters, distributors and traders.
click here to find a list of Hexoprenaline suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.
A Hexoprenaline DMF (Drug Master File) is a document detailing the whole manufacturing process of Hexoprenaline active pharmaceutical ingredient (API) in detail. Different forms of Hexoprenaline DMFs exist exist since differing nations have different regulations, such as Hexoprenaline USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Hexoprenaline DMF submitted to regulatory agencies in the US is known as a USDMF. Hexoprenaline USDMF includes data on Hexoprenaline's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Hexoprenaline USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Hexoprenaline suppliers with USDMF on PharmaCompass.
Hexoprenaline Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Hexoprenaline GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Hexoprenaline GMP manufacturer or Hexoprenaline GMP API supplier for your needs.
A Hexoprenaline CoA (Certificate of Analysis) is a formal document that attests to Hexoprenaline's compliance with Hexoprenaline specifications and serves as a tool for batch-level quality control.
Hexoprenaline CoA mostly includes findings from lab analyses of a specific batch. For each Hexoprenaline CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Hexoprenaline may be tested according to a variety of international standards, such as European Pharmacopoeia (Hexoprenaline EP), Hexoprenaline JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Hexoprenaline USP).
LOOKING FOR A SUPPLIER?
